Granules India secures SBTi validation for net-zero climate strategy

Granules India Limited has achieved a significant milestone in corporate sustainability, receiving validation from the Science Based Targets initiative (SBTi) for its comprehensive climate action plan, the company announced.

Using FY2023 as a baseline, the pharmaceutical business has committed to aggressive goals for reducing greenhouse gas (GHG) emissions, including a 42% decrease in absolute Scope 1, 2, and 3 emissions by fiscal year 2030. By fiscal year 2050, the company wants to achieve net-zero emissions throughout its whole value chain and switch to 100% renewable electricity.

With operations in the US, UK, and India, Granules is a vertically integrated pharmaceutical company that provides services to more than 300 clients in more than 80 countries. The business has regulatory permits from several international health agencies and operates production sites in the US and India. The company’s proactive approach to tackling climate change in the pharmaceutical industry and its strategic focus on sustainable business practices are highlighted by the validation.